On June 23, 2025, TriSalus Life Sciences, Inc. announced an exchange offer to trade shares of Preferred Stock for Common Stock, providing up to 11,860,206 shares in exchange for shares tendered. About 55% of Preferred Stock holders have agreed to participate, aiming to amend the terms governing the Preferred Stock, with the offer expiring on July 23, 2025.